MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about issue of duplicate certificate

15 Dec 2022 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Nestle India 1340.70
Varun Beverages 426.90
Britannia Industries 4819.20
LT Foods 405.20
Hatsun Agro Product 1101.10
View more..